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Abstract
Many pathogens are equipped with factors providing resistance against the bactericidal action of complement. Yersinia
enterocolitica, a Gram-negative enteric pathogen with invasive properties, efficiently resists the deleterious action of human
complement. The major Y. enterocolitica serum resistance determinants include outer membrane proteins YadA and Ail.
Lipopolysaccharide (LPS) O-antigen (O-ag) and outer core (OC) do not contribute directly to complement resistance. The
aim of this study was to analyze a possible mechanism whereby Y. enterocolitica could inhibit the antibody-mediated
classical pathway of complement activation. We show that Y. enterocolitica serotypes O:3, O:8, and O:9 bind C4b-binding
protein (C4bp), an inhibitor of both the classical and lectin pathways of complement. To identify the C4bp receptors on Y.
enterocolitica serotype O:3 surface, a set of mutants expressing YadA, Ail, O-ag, and OC in different combinations was tested
for the ability to bind C4bp. The studies showed that both YadA and Ail acted as C4bp receptors. Ail-mediated C4bp
binding, however, was blocked by the O-ag and OC, and could be observed only with mutants lacking these LPS structures.
C4bp bound to Y. enterocolitica was functionally active and participated in the factor I-mediated degradation of C4b. These
findings show that Y. enterocolitica uses two proteins, YadA and Ail, to bind C4bp. Binding of C4bp could help Y.
enterocolitica to evade complement-mediated clearance in the human host.
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Introduction
Yersinia enterocolitica is a food-borne enteric pathogen of humans
and animals. The invasive strains predominantly belong to
serotypes O:3, O:9, O:5,27 and O:8. Successful colonization of
the intestinal tract is the prerequisite for Y. enterocolitica infection.
Bacteria pass through the acidic content of the stomach and reach
the small intestine. Soon after invading the M cells, bacteria enter
the lamina propria and encounter innate and adaptive immune
responses [1]. Y. enterocolitica can cause enterocolitis, mesenteric
lymphadenitis and, as a post-infectious complication, reactive
arthritis [2]. Typically, infections lead to specific antibody
responses. Mechanisms whereby Y. enterocolitica can evade the
immune system killing and why it causes reactive arthritis are not
fully understood.
The complement system is a crucial constituent of the innate
immunity. Its activation via the classical (CP), lectin (LP) or
alternative pathway (AP) may lead to the killing of microbes by
direct lysis or by complement opsonin-enhanced phagocytosis
[3]. Many pathogens, however, can resist complement attack [4].
Under microbe-free circumstances activation of the complement
system must be effectively controlled as excessive activity could
cause complement consumption, host cell damage or inflamma-
tion. C4b-binding protein (C4bp) down-regulates complement
activity by acting as a fluid-phase inhibitor of the CP or LP [5].
The predominant form of this large (570 kDa) octopus-shaped
glycoprotein [6] consists of seven identical a-chains and one b-
chain [7,8]. The a-a n db-chains are composed of eight and
three complement control protein (CCP) domains each,
respectively. The chains are bundled together by disulphide
bonds at their most C-terminal parts [9]. C4bp inhibits CP and
LP activation at steps that involve C4b. The N-terminal domains
of the C4bp a-chains bind C4b to prevent the assembly of the
CP C3-convertase (C4b2a), accelerate its natural decay and
render C4b susceptible for factor I (FI) -mediated cleavage and
inactivation [10].
Distinct pathogenic microorganisms have been demonstrated to
be able to bind host complement regulators, such as factor H (FH)
or C4bp, to exploit their protective properties and prevent
complement activation on the microbial surfaces. These pathogens
include e.g. Streptococcus pyogenes, S. pneumoniae, Neisseria gonorrhoeae,
N. meningitidis, Borrelia burgdorferi, Escherichia coli K1, Moraxella
catarrhalis, Bordetella pertussis, Haemophilus influenzae and Candida
albicans [11–25].
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[26–29]. This resistance depends mainly on two outer membrane
proteins YadA and Ail [29–33], both expressed exclusively at
37uC. YadA, encoded by the virulence plasmid (pYV), is a trimeric
(monomer 43–45 kDa), lollipop-shaped protein composed of the
head, neck, coiled-coil stalk and membrane anchor domains. The
trimer projects 30 nm out from the outer membrane to form a
fibrillar matrix covering the bacterial surface [34,35].
Ail is a 17 kDa protein encoded chromosomally. It is predicted
to comprise eight membrane spanning b-strands and four
extracellular loops located close to the cell membrane [36,37].
Ail seems to be masked to some extent by the distal parts, O-
antigen (O-ag) and the outer core (OC), of lipopolysaccharide
(LPS) [30]. Unlike in many other Gram-negative bacteria, in Y.
enterocolitica serotype O:3, the O-ag homopolymer and the OC
hexasaccharide are linked to the inner core forming a branched
structure. Though both O-ag and OC are needed for colonization
of the gut [38,39] their role in serum resistance appears to be
indirect [30].
Similar to other pathogens also Y. enterocolitica binds the AP
inhibitor FH [40] and we recently demonstrated that Y. enterocolitica
serotype O:3 bacteria in fact use both YadA and Ail to bind the
AP regulator FH (Biedzka-Sarek et al., submitted for publication)
but no studies on possible regulation of the CP or C4bp binding to
the bacterium have been reported. Since Y. enterocolitica efficiently
escapes all the complement activation pathways we examined in
this study whether Y. enterocolitica also interacts with the major CP
and LP regulator, C4bp. We show that C4bp binding to Y.
enterocolitica is also mediated by YadA and Ail. Since the proteins
are located at different layers on the bacterial surface, Ail is
masked by O-ag and OC while YadA is well surface-exposed. In
consequence, Ail binds C4bp when not blocked by O-ag and OC,
while YadA-mediated C4bp-binding occurs regardless of the LPS
expression status. As an end result the Y. enterocolitica –bound C4bp
retains its function thereby modulating CP and LP activation on
the bacterial surface.
Materials and Methods
Human serum, proteins and reagents
Human serum samples devoid of anti-Yersinia antibodies were
collected from healthy human donors and stored at 270uC.
Serum was heat-inactivated (HIS) by incubation for 30 min at
56uC. C4bp with protein S was purified from pooled human
plasma as described previously [41]. C4b, factor I and factor H
were supplied by Calbiochem. C4bp was labeled with
125I (NEN,
Boston, MA) using the Iodogen method [42]. Triton X-114 (Tx-
114) and heparin sodium salt were purchased from Sigma
Chemicals. Phosphate-buffered saline (PBS), Veronal-buffered
saline (VBS, 1.8 mM Na-barbital, 3.3 mM barbituric acid,
147 mM NaCl, pH 7.5) or Tris-based solutions were used as
assay buffers. 0.1% gelatin – VBS (GVBS) or hypotonic 1/3
GVBS was used in
125I-C4bp binding assays.
Bacteria, plasmids and growth conditions
The bacterial strains and plasmids used in this study are listed in
Table 1. For the C4bp-binding and inhibition assays as well as for
the serum adsorption assay, bacteria were grown in the RPMI
1640 medium at 37uC. This medium increases YadA expression.
Prior to use, exponential-phase bacteria were washed with VBS or
PBS. When appropriate, antibiotics were added to the growth
medium at the following concentrations: kanamycin (Km),
100 mg/ml in agar plates and 20 mg/ml in broth, chloramphenicol
(Clm), 20 mg/ml, and ampicillin, 50 mg/ml.
Construction of strains
To generate a YadA-negative strain of Y. enterocolitica O:8 the
yadA -gene of pYV8081 was cloned in a 4.4 kb XbaI-PvuI fragment
(nt 45398–49838 of pYV8081, accession number NC_008791)
between the EcoRV and XbaI sites of pTM100 to generate plasmid
pYMS3221x. The kanamycin resistance GenBlock (KmGB)
removed by AccI digestion from pUC4K was cloned into the ClaI
site within the yadA gene of pYMS3221x to obtain pYMS3223.
The expression of YadA was abolished by the KmGB-insertion
(data not shown). pYMS3223 was transformed into E. coli S17-1
and mobilized into the wild type Y. enterocolitica O:8 strain 8081
and recombinants, which had lost the vector plasmid due to
double crossing-over between pYV8081 and pYMS3223, were
screened for by looking for Km
R Clm
S strains and one such strain
was named as YeO8-116. YeO8-116 did not express YadA as
verified by SDS-PAGE and autoagglutination tests (data not
shown). Restriction digestions and Southern hybridizations of the
isolated virulence plasmid of YeO8-116 showed that it carried the
KmGB and an inactivated yadA -gene. In addition, YeO8-116 was
calcium dependent, and produced the Yop proteins as released
proteins identical to the wild type strain (data not shown). The
strain Ye08-116 has been used also in earlier studies [43–45].
Plasmid pTM100 was electroporated into the E. coli JM109 strain.
Triparental conjugation was used to mobilize the plasmids
pTM100 and pTM100-ail (from JM109/pTM100 and JM109/
pTM100-ail) with a help of E. coli HB101/pRK2013 to YeO3-c-
Ail-OCR. The matings were performed as described elsewhere
[30].
C4bp binding and inhibition assays
Bacteria grown to mid-logarithmic phase were suspended in
hypotonic 1/3 GVBS. A 50 ml( 3 610
8) aliquot of the bacterial
suspension was incubated with 50 ml of radiolabeled C4bp (5,000–
20,000 cpm) for 30 minutes at 37uC. The assays using BSA (0–
300 nM/assay), unlabeled C4bp (0–300 nM/assay) or factor H
(0–300 nM/assay) as competitors were performed with 40 mlo f
bacteria (3610
7) in reaction mixtures containing
125I-C4bp, or
125I-BSA as a control. The effects of heparin (0–1000 mg/ml) and
NaCl (50–650 mM) on binding were assayed in reaction mixtures
containing
125I-C4bp and 40 ml of bacteria (3610
8). After
incubation the mixtures were centrifuged through 20% (w/v)
sucrose in 1/3 GVBS to pellet the bacteria with the bound
Author Summary
To cause disease in humans, pathogenic bacteria have to
evade the versatile immune system of the host. An
important part of innate immunity is the complement
system that is composed of over 30 proteins on host cells
and in blood able to detect and destroy foreign material.
To survive, bacteria can bind complement regulator
proteins onto their surfaces and thus inhibit the activation
of complement. Previously, it has been shown that food-
borne diarrhoea-causing Yersinia enterocolitica can survive
in human serum because of two bacterial surface proteins,
YadA and Ail. These proteins have been shown to bind a
complement alternative pathway regulator, factor H. Here,
we show that both proteins also bind the classical and
lectin pathway inhibitor, C4b-binding protein. These
results together explain the serum resistance of Y.
enterocolitica. The ability to evade complement attack is
apparently important for the pathogenicity of Yersinia
enterocolitica.
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were cut out and radioactivities in the pellets and supernatants
were measured with a c-counter (Wallac, Finland). The ratios of
bound to total activities were calculated.
Serum adsorption assay
Bacteria (3610
8) were incubated in 5% heat-inactivated
serum at 37uC for 30 min. Thereafter, the bacteria were washed
5–6 times with 400 ml of PBS or 1/3 PBS and bound proteins
were eluted with 0.1 M glycine-HCl (pH 2.7) or PBS, respec-
tively. Supernatants were collected and those acidified due to
elution with glycine were additionally neutralized with 1 M
Tris-HCl (pH 7.5). Samples of the last wash and elution
fractions were subjected to a non-reducing 8% SDS-PAGE gel
electrophoresis and subsequently transferred onto nitrocellulose
membranes. The membranes were blocked and incubated with
1:7,500 diluted sheep anti-human C4bp antiserum (The Binding
Site, Birmingham, UK) and further with 1:10,000 diluted
Table 1. Bacteria and plasmids used in this work.
Bacterial strains and
plasmids Description Source or reference
Y. enterocolitica strains
6471/76 (YeO3) Serotype O:3, fecal isolate, wild type [57]
31761 Serotype O:3, fecal isolate HUSLAB
49008 Serotype O:3, blood isolate HUSLAB
49491 Serotype O:3, blood isolate HUSLAB
YeO3-028 DyadA::Km-GenBlock, Km
R, derivative of YeO3 [30]
YeO3-028-R1 Spontaneous rough derivative of YeO3-028, Km
R [30]
YeO3-028-OCR Spontaneous OC mutant derivative of YeO3-028-R1, Km
R [30]
YeO3-028-OC D(wzx-wbcQ) derivative of YeO3-028, Km
R [30]
6471/76 –c (YeO3-c) Virulence plasmid cured derivative of YeO3 [57]
YeO3-R1 Spontaneous rough derivative of YeO3-c [38]
YeO3-c-OC D(wzx-wbcQ) derivative of YeO3-c [30]
YeO3-c-OCR Spontaneous rough derivative of YeO3-c-OC [30]
YeO3-c-Ail Dail::Km-GenBlock, Km
R, derivative of YeO3-c [30]
YeO3-c-Ail-OC Spontaneous OC mutant derivative of YeO3-c-Ail, Km
R [30]
YeO3-c-Ail-R Spontaneous rough derivative of YeO3-c-Ail, Km
R [30]
YeO3-c-Ail-OCR Spontaneous OC mutant derivative of YeO3-c-Ail-R, Km
R [30]
8081 Serotype O:8, wild type [77]
YeO8-116 DyadA::Km-GenBlock, Km
R, derivative of 8081 This work
90936 Serotype O:9, quality assessment strain HUSLAB
34884 Serotype O:9, blood isolate HUSLAB
27675 Biotype 1A, virulence plasmid negative, fecal isolate HUSLAB
E. coli strains
JM103 sequencing host strain [78]
S17-1 [79]
JM109 reaA1 Dlac-pro endA1 gyrA96 thi-1 hsdR17 supE44
relA1 F9 traD36 proAB
+ lacI
qZDM15
[80]
C600 thi thr leuB tonA lacy supE [81]
HB101/pRK2013 Triparental conjugation helper strain, Km
R [82]
Plasmids
pTM100 Mobilizable derivative of pACYC184, Clm
R [83]
pTM100-ail ail gene cloned as 1711 bp PCR fragment into EcoRV site of pTM100, Clm
R Biedzka-Sarek et al. unpublished
pYMS4450 promoterless yadA cloned into pL2.1; yadA, Amp
R [46]
pL2.1 pBR322 with the Ptac promoter, Amp
R [84]
pYV8081 Virulence plasmid of 8081 [77]
pYMS3221x yadA cloned in 4.4 kb XbaI-PvuI fragment between EcoRV-XbaI sites of pTM100 This work
pYMS3223 Km-GenBlock inserted in the ClaI site of pYMS3221x This work
pUC4K Source of the Km-GenBlock cassette, Amp
R Km
R GE Healthcare Life Sciences, cat. no 27-4958-01
HUSLAB, Helsinki University Central Hospital, Helsinki, Finland.
doi:10.1371/journal.ppat.1000140.t001
Y. enterocolitica YadA and Ail Bind C4bp
PLoS Pathogens | www.plospathogens.org 3 August 2008 | Volume 4 | Issue 8 | e1000140peroxidase-conjugated donkey anti-sheep antiserum (Jackson
Immunoresearch). The proteins were detected by enhanced
chemiluminescence.
Cofactor assay for C4b inactivation
The cofactor assay was performed to analyze the effect of
C4bp on FI-mediated cleavage of C4b. Bacteria (4610
9) were
incubated with C4bp (final concentration 50 mg/ml) in 40 mlo f
PBS for 30 min at 37uC with shaking. After washing for four
times with PBS, bacteria (10
9) were pelleted and resuspended in
30 ml of PBS containing FI (final concentration 50 mg/ml) and
C4b (final concentration 35 mg/ml). The reactions were
incubated for 45 min at 37uC with shaking. A reaction where
C4b and FI were incubated for 45 min at 37uCw i t h5 0mg/ml of
C4bp was used a positive control. In addition, a negative control
comprising of C4b and FI incubated without C4bp, was
included. After incubation the samples were centrifuged,
supernatants were collected, mixed with Laemmli buffer and
subjected to 12.5% SDS-PAGE and immunoblotting using
rabbit anti-human C4c antiserum (DAKO, 1:5,000). The bound
anti-human C4c antibodies were detected using HRP-conjugat-
ed swine anti-rabbit IgG (DAKO; 1:5,000). Supernatants were
also analyzed by immunoblotting with sheep anti-human C4bp
antiserum to exclude unbound C4bp.
Purification of YadA using Triton X-114 (Tx-114)
The extracts Tx-YadA (from E. coli JM103/pYMS4450), Tx-Ail
(from E. coli JM109/pTM100-ail) and vector control extracts from
E. coli strains JM103/pL2.1 and JM109/pTM100 were prepared
as described previously [46] with slight modifications. Briefly,
bacteria were grown overnight at 37uC in 400 ml of Luria broth
supplemented with appropriate antibiotics. Bacteria were centri-
fuged (3,0006g, 15 min) and incubated on ice for 1 h in 20 ml of
lysis buffer (10 mM EDTA, 50 mM glucose, 25 mM Tris-HCl
[pH 8.0], 5 mg/ml of lysozyme). Triton X-114, prepared as
described previously [47], was then added to the lysate to a final
concentration of 5%. The extraction was carried out by incubating
the mixture at 4uC for 24 h with slow rocking. Subsequently, the
mixture was incubated overnight at 37uC to separate the water
and Tx-114 phases followed by centrifugation (4,0006g, 10 min)
to clear the phases. The Tx-114 phase was recovered and stored at
4uC.
Purification of Ail using b-octylglucoside (OG)
The OG-Ail and vector control extracts from E. coli JM109/
pTM100-ail and JM109/pTM100 were prepared using OG as
described elsewhere [37].
C4bp ligand blotting
Samples from Tx-YadA, Tx-Ail and OG-Ail as well as from
the three control extracts (see above) were run into a 7.5–17.5%
SDS-PAGE gel. Proteins were electrotransferred onto a nitro-
cellulose membrane. Membranes were blocked with 5%
skimmed milk and incubated with the radioactively labeled
C4bp (10
6 cpm/assay) or 5% NHS. Binding of the protein was
detected by autoradiography or immunoblotting with rabbit
anti-human C4bp (5 mg/ml) as described above. YadA on the
membrane was detected by immunoblotting with the monoclo-
nal antibody 3G12 [48].
Accession numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank/) acces-
sionnumberforthegenesequenceofYeO:8YadAisX13881.Forthe
protein sequences the accession numbers are CAE53849 for Ail (Ye
serotype O:3) and CAA32086 for YadA (Ye 6471/76 serotype O:3).
Results
Y. enterocolitica binds complement regulator C4bp
In order to study whether Y. enterocolitica binds the classical and
lectin pathway complement inhibitor C4bp serotype O:3, O:8,
O:9 and biotype 1A strains were incubated with
125I-C4bp and
phase-separated from unbound
125I-C4bp by centrifugation
through 20% sucrose. As shown in Fig. 1, all strains belonging
to pathogenic pYV-positive serotypes O:3, O:8 and O:9 bound
125I-C4bp with a binding capacity of ,20–40%. The less virulent
pYV-negative biotype 1A Y. enterocolitica strain (27675) bound
125I-
C4bp significantly less or not at all. The binding percentages by
strains that did not bind C4bp (including E. coli K12 C600) ranged
between 1–8% under the conditions used (not shown).
Cofactor activity of Y. enterocolitica–bound C4bp
To examine cofactor activity of the Y. enterocolitica–bound C4bp,
serotype O:3 wild type bacteria and Ail-expressing YeO3-028-
OCR strain were incubated with purified C4bp as described in
Experimental procedures. A clinical isolate, less virulent Ye
biotype 1A strain was included as a control because the strain
bound C4bp clearly less than the other two strains used. Unbound
C4bp was removed by extensive washing with PBS. The bacteria
with surface-bound C4bp were subsequently incubated with FI
and C4b. Following the incubation, the C4bp-cofactor activity was
verified by immunodetection of C4b-cleavage products in the
supernatants using anti-C4c antibodies. As a polyclonal antibody
the anti-C4c antibody detects the a9-chain, the b-chain and
cleavage fragments of the a9-chain. As shown in Fig. 2, Y.
enterocolitica-bound C4bp displayed cofactor activity for FI-
mediated cleavage of C4b with both strains YeO3 and Ye-028-
OCR. This is indicated by the appearance of the C4b a9-chain
Figure 1. Binding of
125I-C4bp to Y. enterocolitica serotypes O:3,
O:8, O:9 and biotype 1A. Indicated strains were incubated with
125I-
C4bp for 30 min at 37uC. Subsequently, they were centrifuged through
20% sucrose to separate bacteria-bound
125I-C4bp from the unbound
protein. Radioactivity was measured with a c-counter. The binding of
125I-C4bp is expressed as percentage of the total radioactivity.
Mean6SD values from two experiments performed in duplicate are
shown.
doi:10.1371/journal.ppat.1000140.g001
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fragment generated by Y. enterocolitica-bound C4bp corresponds to
the fragment generated in the absence of bacteria by FI incubated
with C4bp and C4b (Fig. 2, positive control lane). Clearly less
cleavage products were seen with the biotype 1A strain, as
expected based on the low binding of radiolabeled C4bp. No
cleavage was observed when bacteria were incubated with FI and
C4b suggesting that C4bp bound to bacterial surface is essential
for the observed C4b cleavage (data not shown).
Identification of C4bp receptors on Y. enterocolitica
Serum resistance of Y. enterocolitica depends greatly on the
expression of the pYV-encoded YadA protein [29–31,49,50].
Thus, we first examined the role of YadA in the acquisition of
serum C4bp. To this end we incubated the wild type O:3 and O:8
strains (YeO3 and 8081, Table 1) and their YadA-negative pYV-
positive derivatives (YeO3-028 and YeO8-116, respectively) in
heat-inactivated serum (HIS). After extensive washings, the
bacteria-bound serum proteins were eluted and subjected to
immunoblotting using anti-C4bp antiserum. Material eluted from
the wild type O:3 and O:8 strains contained C4bp while strains
lacking YadA displayed significantly less C4bp in the eluted
fractions (Fig. 3). This suggested that YadA is involved in C4bp
binding. Residual C4bp-binding by YadA-negative strains,
however, suggested a role for other Y. enterocolitica factor(s) in
C4bp-binding.
To identify C4bp receptors on Y. enterocolitica O:3 surface a set of
12 strains expressing YadA, Ail, LPS O-ag and OC in different
combinations was tested for the ability to bind
125I-C4bp in 1/3
GVBS buffer containing 50 mM NaCl. YadA was indispensable
for the maximal C4bp binding. Both pYV- and YadA-negative
strains (YeO3-c and YeO3-028, respectively) displayed equally low
levels of bound C4bp suggesting that the main factor responsible
for the binding is pYV-encoded YadA (Fig. 4). Almost all YadA-
negative strains bound much less C4bp than the wild type strain.
The two sole exceptions were strains expressing Ail in the absence
of both O-ag and OC (Fig. 4, YeO3-c-OCR and YeO3-028-
OCR). Both Ail-expressing strains were found to bind
125I-C4bp.
The fact that the removal of either O-ag (Fig. 4, YeO3-028-R,
YeO3-R1) or OC (Fig. 5, YeO3-028-OC, YeO3-c-OC) was not
sufficient to promote Ail-C4bp interaction suggests that either of
them can block Ail-mediated C4bp-binding to the bacterial
surface. To confirm Ail-mediated C4bp binding, we complement-
ed in trans the YeO3-c-Ail-OCR strain (YadA
2, Ail
2, O-ag
2,
OC
2) with pTM100-ail carrying the cloned ail gene. The resulting
strain YeO3-c-Ail-OCR/pTM100-ail restored C4bp-binding abil-
ity, while the vector control YeO3-c-Ail-OCR/pTM100 strain
was unable to bind the CP-regulator (Fig. 5). C4bp binding was
shown to be specific since no binding of
125I-labeled control
protein, BSA, to any of the tested strains was detected (Fig. 5). In
addition, the strain with trans-complemented ail (YeO3-c-Ail-
OCR/pTM100-ail) displayed about four-fold higher C4bp
binding capacity (80%) than the YeO3-c-OCR strain expressing
Ail from the chromosomally-located ail gene (Figs. 4 and 5). This
difference, however, can be explained by the overexpression of Ail
by pTM100-ail due to a copy-number effect (data not shown).
Figure 2. Cofactor activity of Y. enterocolitica-bound C4bp for
C4b cleavage. Y. enterocolitica serotype O:3 wild-type bacteria (YeO3),
YadA-negative less virulent biotype 1A strain 27675 (BT 1A) and Ail-
expressing strain YeO3-028-OCR were preincubated with C4bp and
after extensive washings exposed to factor I and C4b. C4b and its
cleavage products from the supernatants were detected using
polyclonal antibodies against C4c. As positive and negative controls,
assays containing C4b and FI with or without C4bp, respectively, were
included. Inactivation of C4b is demonstrated by the appearance of C4b
cleavage fragments (indicated with arrows).
doi:10.1371/journal.ppat.1000140.g002
Figure 3. Binding of serum C4bp to the wild type and YadA-
negative Y. enterocolitica serotypes O:3 and O:8. Wild type
bacteria (Ye03 and 8081) and their YadA-negative derivatives (YeO3-028
and YeO8-116, respectively) (3610
8) were incubated in 5% heat-
inactivated serum (HIS) for 30 min. Bacteria washed in 1/3 PBS were
subjected to elution with PBS while those washed with PBS were
subjected to elution with 0.1 M glycine-HCl (pH 2.7). The 1/3 PBS or PBS
wash fractions (w1 and w2, respectively) and PBS or 0.1 M glycine-HCl
(pH 2.7) elute fractions (e1 and e2, respectively) were separated by 8%
non-reducing SDS-PAGE and analyzed by immunoblotting using a
sheep anti human-C4bp antiserum.
doi:10.1371/journal.ppat.1000140.g003
Figure 4. Binding of
125I-C4bp to Y. enterocolitica serotype O:3
strains. The bacteria were incubated with
125I-C4bp as described in
Fig. 1. The factors expressed by Ye O:3 strains are marked as follows:
YadA, Y; Ail, A, O-ag,N; OC, C. Strains carrying the pYV plasmid are
marked with +.
doi:10.1371/journal.ppat.1000140.g004
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Ail- negative strains expressing full LPS (YeO3-c-Ail) or its rough
(YeO3-c-Ail-R) or OC-less (YeO3-c-Ail-OC) derivatives bound
only negligible amounts of C4bp (Fig. 4).
To see a direct interaction of YadA and Ail with C4bp we tested
the binding of serum C4bp to TritonX-114 extracted YadA and
Ail, Tx-YadA and Tx-Ail, respectively, in affinity blotting. C4bp
binding to YadA trimer was observed (Fig. 6). Binding to Tx-Ail,
however, could not be detected (data not shown). Also b-
octylglucoside-extracted Ail (OG-Ail) failed to bind C4bp when
tested in a ligand blotting assay (data not shown). This suggests
that Ail loses its appropriate conformational structure upon
extraction and/or processing for SDS-PAGE.
Effect of salt, heparin and factor H on C4bp binding to Y.
enterocolitica
Electrostatic forces and ion pairings have been suggested to be
essential for C4bp binding to C4b [51]. The nature of C4bp
binding to YadA and Ail was examined using the wild type strain
YeO3 that expresses both YadA and Ail (but the latter is blocked
by O-ag and OC as demonstrated above), mutant strain YeO3-
028-OCR that expresses unblocked Ail, and YeO3-c-Ail-OCR/
pTM100-ail expressing Ail in trans. Bacteria were incubated with
125I-C4bp in 1/3 GVBS alone or supplemented with NaCl to
create a salt-concentration gradient ranging from 50 to 650 mM.
After centrifugation through 20% sucrose bound
125I-C4bp was
measured using a gamma-counter. In general, at low salt
concentrations both YadA- and Ail-mediated C4bp-binding was
the highest and showed a tendency to decrease with increasing salt
concentrations (Fig. 7A). The C4bp binding to YeO3-c-Ail-OCR/
pTM100-ail was not affected by an increase in salt concentration.
YadA-mediated C4bp-binding, however, was more salt sensitive
than Ail-mediated binding. A two-fold decrease in C4bp binding
to YadA (strain YeO3) was observed already at NaCl concentra-
tion of 100 mM while Ail-mediated C4bp-binding at this salt
concentration was not affected. Thus, C4bp binding to YadA
depends on ionic interactions between the proteins. The fact that
C4bp-binding to YadA, similarly as that to C4b [51], was almost
completely abolished in the presence of 250 mM salt (Fig. 7A),
suggests that YadA and C4b have affinity for C4bp at site(s) with
similar properties.
Heparin binds to the N-termini of C4bp a-chains, i.e. to CCP1-
3 [52–54]. We tested whether heparin inhibits the binding of C4bp
to YadA- or Ail-expressing strains (Fig. 7B). Bacteria were
incubated with
125I-C4bp in the presence of heparin (0–
1000 mg/ml). As shown in Fig. 7B heparin efficiently and dose-
dependently inhibited
125I-C4bp binding to Ail, while significant
reduction of
125I-C4bp binding to YadA could only be observed at
the highest heparin concentration of 1000 mg/ml. Delayed
response to heparin was observed with the strain over-expressing
Ail (YeO3-c-Ail-OCR/pTM100-ail).
T h er e l a t i v eb i n d i n go f
125I-C4bp to Ail-expressing strain Ye-
028-OCR could be dose-dependently reduced to 55% by
adding 0–300 nM factor H. C4bp binding to YeO8 wt strain
was not affected by the addition of 0–300 nM factor H (data
not shown).
Specificity of C4bp binding to Yersinia
To verify whether YadA- and Ail-mediated
125I-C4bp-binding
was specific, wild type and YeO3-028-OCR strains were
incubated with
125I-C4bp in the presence of unlabeled C4bp or
BSA (0–300 nM). In this assay, ten-fold less bacteria (3610
7) were
used when compared to the heparin and salt inhibition
experiments. Under these conditions
125I-C4bp binding to both,
YadA (wild type) and Ail (YeO3-028-OCR and YeO3-c-Ail-
OCR/pTM100-ail), was significantly inhibited in the presence of
unlabeled C4bp (Fig. 7C). YadA-mediated
125I-C4bp-binding was
inhibited to a greater extent than that of Ail. The presence of BSA
did not affect the
125I-C4bp binding neither to YadA nor to Ail
(Fig. 7D). With ten-fold higher numbers of bacteria, the inhibition
with unlabeled C4bp could not be observed possibly because of
excessive amounts of C4bp-binding surface proteins, YadA and Ail
(data not shown).
Figure 5. Binding of
125I-C4bp to Ail. The strain YeO3-c-Ail-OCR
was complemented in trans with pTM100-ail expressing the cloned ail
gene (YeO3-c-Ail-OCR/pTM100-ail). YeO3-c-Ail-OCR/pTM100 was used
as the vector control. The bacteria were incubated with
125I-C4bp or
125I-BSA as described in Fig. 1.
doi:10.1371/journal.ppat.1000140.g005
Figure 6. Affinity blotting analysis of C4bp-binding to Triton X-
114-extracted YadA. Membrane proteins were extracted from E. coli
JM103/pYMS4450 expressing YadA of Y. enterocolitica serotype O:3 (Tx-
YadA) and E. coli JM103/pL2.1 carrying the empty vector (Tx-Ctrl).
Extracts were subjected to SDS-PAGE and proteins were transferred
onto nitrocellulose membrane. The membrane was blocked in 5%
skimmed milk in PBS and incubated with 5% normal human serum.
After washing C4bp-bound to extracted proteins was detected using
rabbit anti-human C4bp antibody (anti-C4bp). The YadA-bound C4bp is
indicated with an arrow. In parallel, YadA protein on the membrane was
detected by the monoclonal antibody 3G12 (anti-YadA).
doi:10.1371/journal.ppat.1000140.g006
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The complement system is an essential part of host defense
against many microorganisms. A number of pathogens, however,
have evolved mechanisms to subvert complement activation at
different steps of the cascade. To survive and establish infection in
the gut and surrounding tissues, Y. enterocolitica must resist
complement-mediated opsonization and lysis. It is thus equipped
with surface factors that confer resistance to serum, such as the
outer membrane proteins, YadA and Ail [29–33,55]. Although it
has been shown that Ail promotes resistance to complement
killing, the mechanism of Ail-mediated serum resistance has
remained unknown. YadA, in turn, has been shown to be the
major serum resistance determinant of Y. enterocolitica [29,30,49].
Thus, not surprisingly, mechanisms underlying YadA-mediated
resistance have for long been of interest. It has been speculated
that the formation of YadA-composed velvet-like coat on the
bacterial surface could by itself act as a shield protecting against
complement [56,57]. There is evidence, however, for YadA-
mediated binding of the alternative pathway regulator FH and
inhibition of the complement cascade at both C3 and C9 levels
[40,58]. This manifests as a reduced binding of C3b and as a
failure of the membrane attack complex to incorporate into the
outer membrane of Y. enterocolitica [49]. Lipopolysaccharide O-ag
and OC are involved in complement-resistance indirectly [30].
They block outer membrane proteins, such as small-sized Ail,
thereby having a negative influence on bacterial resistance to
serum [30].
This study demonstrated a novel immune evasion mechanism of
Y. enterocolitica, C4bp binding by YadA and Ail proteins. All
serotypes tested, O:3, O:8 and O:9, were shown to bind the host
complement regulator C4bp to avoid opsonophagocytosis and
bactericidal action of serum (Fig. 1). The bacteria also acquired
this CP-inhibitor from serum, as demonstrated by serum
adsorption assays (Fig. 3). In addition, binding of purified
radiolabeled C4bp to Y. enterocolitica could be observed (Figs. 1
and 4). This shows that the binding is direct and does not involve
other serum proteins. Importantly, FI cofactor assay showed that
C4bp bound to Y. enterocolitica surface was functionally active
(Fig. 2). By binding C4bp Y. enterocolitica can thus inhibit antibody-
mediated CP, and the LP.
C4bpreceptorsonY.enterocoliticasurfacewereidentifiedusingaset
of serotype O:3 mutants expressing YadA, Ail, O-ag and OC in
different combinations (Fig. 4). Analyses of
125I-labeled C4bp
binding to Y. enterocolitica O:3 strains showed that YadA was crucial
for capturing this CP regulator. Therefore, YadA- or pYV-negative
mutants bound only marginal amounts of C4bp, exceptions being
the strains expressing Ail in the absence of O-ag and OC (Fig. 4).
Thus, Ail could bind C4bp solely when accessible on the outer
membrane.Thiswasadditionallyconfirmed bytrans-complementing
Figure 7. The effect of NaCl (A), heparin (B), unlabeled C4bp (C) or BSA (D) on binding of
125I-C4bp to Y. enterocolitica. Wild type
(YadA+ Ail+, YeO3) and YadA-negative (YadA- Ail+, YeO3-028-OCR and YadA- Ail+ (complemented), YeO3-c-Ail-OCR/pTM100-ail) bacteria were
incubated with
125I-C4bp as described in Fig. 1. The binding is presented as percentage of the
125I-C4bp binding occurring in the presence of 50 mM
NaCl without any additives. In the wild type strain Ail protein is masked by O-ag and OC and thus the binding represents properties of the YadA-C4bp
interaction.
doi:10.1371/journal.ppat.1000140.g007
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strain lacks O-ag and OC, C4bp binding to Ail was strongly favored
(Fig. 5). The demonstration of C4bp receptors as YadA and Ail
correlated with the previously published serum resistance results of
these Ye O:3 strains [30]. These results revealed that the major
serum resistance determinant of Y. enterocolitica was YadA and that
the removal of LPS O-ag and OC potentiated Ail-mediated
complement resistance of YadA-negative strains [30]. It is possible
that during infection the production of LPS, O-ag, and OC is
suppressed. Similar phenomenon has been observed for Salmonella
[59,60]. In addition, LPS was shown not to contribute to serum
resistance directly. Accordingly, in the present work we observed
binding of C4bp neither to O-ag nor to OC (Fig. 4).
YadA is a member of a large family of surface proteins of Gram-
negative bacteria. These trimeric autotransporter proteins exert
many functions and are required for full virulence of pathogenic
species. Some of these proteins, such as Actinobacillus actinomyctem-
comitans Omp100, E. coli EibD, Haemophilus ducreyi DsrA and
Moraxella catarrhalis UspA1 and UspA2, confer resistance to serum
[14,61–66]. Interestingly, DsrA, UspA1 and UspA2 have been
shown to capture C4bp [14,63]. Apparently, C4bp-binding is a
mechanism shared by multiple members of this family of
autotransporters. The interaction between YadA and C4bp
appeared to be ionic strength-dependent (Fig. 7A). Interestingly,
salt inhibited YadA-C4bp interaction similarly to that between
C4bp and C4b [51]. The fact that the positively charged cluster of
amino acids between CCP1 and CCP2 is involved in C4b binding
[54] would suggest that these CCPs are needed also for the YadA-
C4bp interaction. Heparin inhibition assay, however, showed
discordant results (Fig. 7B). The electronegative polysaccharide,
heparin, alike C4b, binds to CCP1-2, and thus partially competes
with C4b for C4bp binding [52–54]. Heparin inhibition data
showed an initial increase in C4bp binding to YadA at low heparin
concentrations (Fig. 7B). This could be theoretically explained by
the binding of C4bp oligomers, formed in the presence of heparin,
to YadA. Higher doses of heparin inhibited rather weakly C4bp
binding to YadA, and 50% inhibition of the binding could only be
observed at the highest heparin concentration of 1 mg/ml
(Fig. 7B). Thus, the C4bp binding sites for C4b and YadA do
not seem to be identical, but most likely are overlapping.
Electrostatic forces thus mediate the YadA-C4bp complex
formation.
Ail belongs to a family of b-barrel outer membrane proteins that
include Salmonella enterica serovar Typhimurium PagC and Rck,
and Enterobacter cloacae OmpX [67–71]. These proteins, though
highly similar in structure, do not appear to share many of their
functions. The only protein sharing serum resistance phenotype
with Ail is Rck [72]. Here we provided evidence for Ail-mediated
C4bp binding. The mechanism of C4bp binding to Ail appeared
to be different from that of C4b and YadA, as heparin efficiently
and dose-dependently inhibited the binding of C4bp to Ail
(Fig. 7B). This observation suggested that Ail-binding involved the
CCP1-3 domains of C4bp a-chain. The Ail-C4bp interaction was
also less sensitive to salt when compared to that of YadA-C4bp
(Fig. 7A) or C4b-C4bp interactions [51]. Thus, other than
electrostatic forces, e.g. hydrophobicity, could also be involved
in this interaction. Ail binding sites on C4bp, however, are most
likely not fully equivalent, though possibly overlapping, with those
involved in C4b-C4bp or YadA-C4bp interactions.
Y. pestis, the causative agent of plague, has been shown to be
resistant against complement-mediated killing and to bind C4bp
[25]. In contrast to Y. enterocolitica, the surface protein Ail (also
called OmpX) seems to be solely responsible for the serum
resistance property in Y. pestis [73,74]. Y. pestis Ail protein shares
about 70% sequence identity with Y. enterocolitica Ail. As a result of
several gene mutations, however, Y. pestis does not express YadA
or O-ag [75]. Here we have shown that in YadA-negative Y.
enterocolitica strain, removing the Ail-masking O-ag and OC greatly
enhances the binding of C4bp (Fig. 4). Based on these previous
findings and our current results about Ail binding C4bp, it is
probable that constitutively expressed Ail binds C4bp also on the
surface of Y. pestis and is, at least partly, responsible for the high
complement resistance.
In summary, this study provides the first evidence that Y.
enterocolitica acquires the CP regulator C4bp in a functionally active
form able to promote degradation of C4b. The binding depends
on the two outer membrane proteins YadA and Ail, the latter
binding C4bp only when well surface-exposed, i.e., not blocked by
O-ag or OC (Fig. 8). Y. enterocolitica is thus able to take advantage of
the captured C4bp and is likely to be able to prevent both C4b-
mediated opsonization and formation of the CP C3-convertase
(C4bC2a). Consequently, the bacteria can avoid complement-
mediated lysis and increase their chances to survive in the human
host. It is also remarkable that Y. enterocolitica uses both YadA and
Ail to recruit both the AP and CP regulators FH and C4bp,
respectively. This way the pathogen can ascertain that it will be
protected from complement activation during different phases of
infection.
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Figure 8. Schematic model of C4bp binding to Y. enterocolitica
surface structures. Y. enterocolitica expresses outer membrane
proteins, YadA and Ail, that are able to capture C4bp. Ail, however, is
masked by LPS O-ag chains and OC branches. Hexasaccharide OC is
abundant on the Y. enterocolitica surface and forms a branched
structure with O-ag. Removal of the O-ag and OC can unveil Ail and
promotes Ail-mediated C4bp binding. C4bp [59,60], YadA [76], Ail, outer
membrane and O-antigen (1 nm per sugar residue) are drawn to scale.
doi:10.1371/journal.ppat.1000140.g008
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